Literature DB >> 24333503

The role of FAK in tumor metabolism and therapy.

Jianliang Zhang1, Steven N Hochwald2.   

Abstract

Focal adhesion kinase (FAK) plays a vital role in tumor cell proliferation, survival and migration. Altered metabolic pathways fuel rapid tumor growth by accelerating glucose, lipid and glutamine processing. Besides the mitogenic effects of FAK, evidence is accumulating supporting the association between hyper-activated FAK and aberrant metabolism in tumorigenesis. FAK can promote glucose consumption, lipogenesis, and glutamine dependency to promote cancer cell proliferation, motility, and survival. Clinical studies demonstrate that FAK-related alterations of tumor metabolism are associated with increased risk of developing solid tumors. Since FAK contributes to the malignant phenotype, small molecule inhibition of FAK-stimulated bioenergetic and biosynthetic processes can provide a novel approach for therapeutic intervention in tumor growth and invasion.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Focal adhesion kinase; Glutamine; Lipogenesis; Molecular targeting; Motility; Proliferation

Mesh:

Substances:

Year:  2013        PMID: 24333503      PMCID: PMC6349254          DOI: 10.1016/j.pharmthera.2013.12.003

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  146 in total

1.  Targets of gene amplification and overexpression at 17q in gastric cancer.

Authors:  Asta Varis; Maija Wolf; Outi Monni; Marja-Leena Vakkari; Arto Kokkola; Chris Moskaluk; Henry Frierson; Steven M Powell; Sakari Knuutila; Anne Kallioniemi; Wa'el El-Rifai
Journal:  Cancer Res       Date:  2002-05-01       Impact factor: 12.701

2.  Focal adhesion kinase (FAK) regulates insulin-stimulated glycogen synthesis in hepatocytes.

Authors:  Danshan Huang; Anthony T Cheung; J Thomas Parsons; Michael Bryer-Ash
Journal:  J Biol Chem       Date:  2002-01-23       Impact factor: 5.157

3.  Immunohistochemical analyses of focal adhesion kinase expression in benign and malignant human breast and colon tissues: correlation with preinvasive and invasive phenotypes.

Authors:  W G Cance; J E Harris; M V Iacocca; E Roche; X Yang; J Chang; S Simkins; L Xu
Journal:  Clin Cancer Res       Date:  2000-06       Impact factor: 12.531

4.  Focal adhesion kinase and Src mediate integrin regulation of insulin receptor phosphorylation.

Authors:  S El Annabi; N Gautier; V Baron
Journal:  FEBS Lett       Date:  2001-11-02       Impact factor: 4.124

5.  Neuregulin induces the rapid association of focal adhesion kinase with the erbB2-erbB3 receptor complex in schwann cells.

Authors:  T Vartanian; A Goodearl; S Lefebvre; S K Park; G Fischbach
Journal:  Biochem Biophys Res Commun       Date:  2000-05-10       Impact factor: 3.575

6.  Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells.

Authors:  C Lobo; M A Ruiz-Bellido; J C Aledo; J Márquez; I Núñez De Castro; F J Alonso
Journal:  Biochem J       Date:  2000-06-01       Impact factor: 3.857

Review 7.  The focal adhesion kinase--a regulator of cell migration and invasion.

Authors:  Christof R Hauck; Datsun A Hsia; David D Schlaepfer
Journal:  IUBMB Life       Date:  2002-02       Impact factor: 3.885

8.  Cell adhesion and focal adhesion kinase regulate insulin receptor substrate-1 expression.

Authors:  P Lebrun; V Baron; C R Hauck; D D Schlaepfer; E Van Obberghen
Journal:  J Biol Chem       Date:  2000-12-08       Impact factor: 5.157

9.  Focal adhesion kinase tyrosine phosphorylation is associated with myogenesis and modulated by insulin.

Authors:  H L Goel; C S Dey
Journal:  Cell Prolif       Date:  2002-06       Impact factor: 6.831

10.  Cosignaling of NCAM via lipid rafts and the FGF receptor is required for neuritogenesis.

Authors:  Philipp Niethammer; Markus Delling; Vladimir Sytnyk; Alexander Dityatev; Kiyoko Fukami; Melitta Schachner
Journal:  J Cell Biol       Date:  2002-04-29       Impact factor: 10.539

View more
  34 in total

Review 1.  Stiffness Sensing by Cells.

Authors:  Paul A Janmey; Daniel A Fletcher; Cynthia A Reinhart-King
Journal:  Physiol Rev       Date:  2019-11-21       Impact factor: 37.312

2.  PTK2-mediated degradation of ATG3 impedes cancer cells susceptible to DNA damage treatment.

Authors:  Ke Ma; Wan Fu; Ming Tang; Chaohua Zhang; Tianyun Hou; Ran Li; Xiaopeng Lu; Yanan Wang; Jingyi Zhou; Xue Li; Luyao Zhang; Lina Wang; Ying Zhao; Wei-Guo Zhu
Journal:  Autophagy       Date:  2017-01-19       Impact factor: 16.016

Review 3.  The extracellular matrix modulates the hallmarks of cancer.

Authors:  Michael W Pickup; Janna K Mouw; Valerie M Weaver
Journal:  EMBO Rep       Date:  2014-11-08       Impact factor: 8.807

4.  A small molecule FAK kinase inhibitor, GSK2256098, inhibits growth and survival of pancreatic ductal adenocarcinoma cells.

Authors:  Jianliang Zhang; Di-Hua He; Maria Zajac-Kaye; Steven N Hochwald
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

Review 5.  Imidazoles as potential anticancer agents.

Authors:  Imran Ali; Mohammad Nadeem Lone; Haasan Y Aboul-Enein
Journal:  Medchemcomm       Date:  2017-04-13       Impact factor: 3.597

6.  Focal adhesion kinase-promoted tumor glucose metabolism is associated with a shift of mitochondrial respiration to glycolysis.

Authors:  J Zhang; Q Gao; Y Zhou; U Dier; N Hempel; S N Hochwald
Journal:  Oncogene       Date:  2015-06-29       Impact factor: 9.867

7.  Role of Ubiquitylation in Controlling Suppressor of Cytokine Signalling 3 (SOCS3) Function and Expression.

Authors:  Jamie J L Williams; Kirsten M A Munro; Timothy M Palmer
Journal:  Cells       Date:  2014-05-30       Impact factor: 6.600

8.  Ruthenium polypyridyl complex inhibits growth and metastasis of breast cancer cells by suppressing FAK signaling with enhancement of TRAIL-induced apoptosis.

Authors:  Wenqiang Cao; Wenjie Zheng; Tianfeng Chen
Journal:  Sci Rep       Date:  2015-03-17       Impact factor: 4.379

9.  The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction.

Authors:  Jean-Baptiste Oudart; Manon Doué; Alexia Vautrin; Bertrand Brassart; Christèle Sellier; Aurelie Dupont-Deshorgue; Jean-Claude Monboisse; François-Xavier Maquart; Sylvie Brassart-Pasco; Laurent Ramont
Journal:  Oncotarget       Date:  2016-01-12

10.  Polyphenolic Compounds of Crataegus Berry, Leaf, and Flower Extracts Affect Viability and Invasive Potential of Human Glioblastoma Cells.

Authors:  Natalia Żurek; Olena Karatsai; Maria Jolanta Rędowicz; Ireneusz Tomasz Kapusta
Journal:  Molecules       Date:  2021-05-01       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.